Invention Grant
US07674792B2 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
失效
5（Z）-5-（6-喹喔啉亚甲基）-2- [2,6-二氯苯基]氨基] -1,3-噻唑-4（5H） - 酮
![5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one](/docs/US/2010-03-09/US07674792B2/abs.jpg.600x600.jpg)
- Patent Title: 5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one
- Patent Title (中): 5（Z）-5-（6-喹喔啉亚甲基）-2- [2,6-二氯苯基]氨基] -1,3-噻唑-4（5H） - 酮
-
Application No.: US11726741Application Date: 2007-03-22
-
Publication No.: US07674792B2Publication Date: 2010-03-09
- Inventor: Kevin J. Duffy , Duke M. Fitch , Beth A. Norton
- Applicant: Kevin J. Duffy , Duke M. Fitch , Beth A. Norton
- Applicant Address: US PA Philadelphia
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US PA Philadelphia
- Agent Wayne J. Dustman; Edward R. Gimmi; Charles M. Kinzig
- Main IPC: A61K31/498
- IPC: A61K31/498 ; C07D417/06
![5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one](/abs-image/US/2010/03/09/US07674792B2/abs.jpg.150x150.jpg)
Abstract:
Invented is the compound (5Z)-5-(6-quinoxalinylmethylidene)-2-[(2,6 -dichlorophenyl)amino]-1,3-thiazol-4(5H)-one, and/or pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are pharmaceutical compositions containing this compound, methods of preparing this compound and pharmaceutically acceptable salts, hydrates, solvates and pro-drugs thereof. Also invented are methods of using this compound as an inhibitor of hYAK3 proteins.
Public/Granted literature
- US20070179144A1 5(Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5H)-one Public/Granted day:2007-08-02
Information query
IPC分类:
